Abstract
Background
Cervical cancer is a major contributor to mortality and morbidity in women. PAP test is commonly used for cervical cancer screening having low sensitivity and subjectivity, lack of permanent record and over estimation. Here, Smartscope visual screening test is compared with PAP test. This study aims to compare SS test with PAP and its management in resource limited countries.
Materials and Methods
A prospective observational study conducted at MKCG MCH OPD over 8 months. About 96 women in the age group 25–65 years underwent PAP and SS test. Screen positive on any one test were subjected to colposcopy and biopsy.
Results
Out of 96 screened patients, 37 women were found PAP positive and 44 were tested positive through Smartscope (VIA and VILI), of which about 15 patients underwent thermal ablation and symptoms resolved in 13 of them. Out of 21 patients who underwent cervical biopsy showed a maximum of 58.6% as CIN I, 13.7% of CIN II with no case suggestive of advanced cancer. These patients were treated on the basis of SEE and TREAT approach and followed up.
Conclusion
SS test has greater potential as a primary screening test in low resource setting due to its better sensitivity and NPV as compared to PAP test.
Similar content being viewed by others
References
Ami YS, Singh R. A prospective study of comparison Pap’s Smear, Vili’s test and colposcopy in cervical cancer screening. Int J Med Res Heal Sci. 2016;5:50–7.
Antal G, Kierski J, Stanley K. Control of cancer of the cervix uteri. Bull World Health Organ. 1986;4:607–18.
Bae SN, Kim JH, Lee CW, et al. Correlation between the digital cervicography and pathological diagnosis performed at private clinics in Korea. Int J Med Sci. 2012;9:698–703.
Basu P, Banerjee D, Mittal S, et al. Evaluation of a compact, rechargeable, magnifying device to triage VIA and HPV positive women in a cervical cancer screening program in rural India. Cancer Causes Control. 2016;27:1253–9.
Bedell SL, Goldstein LS, Goldstein AR, Goldstein AT. Cervical cancer screening: past, present, and future. Sex Med Rev. 2020;8:28–37.
Bhattacharyya AK, Nath JD, Deka H. Comparative study between pap smear and visual inspection with acetic acid (via) in screening of CIN and early cervical cancer. J Midlife Health. 2015;6:53–8.
Bobdey S, Sathwara J, Jain A, Balasubramaniam G. Burden of cervical cancer and role of screening in India. Indian J Med Paediatr Oncol. 2016;37:278–85.
Practice CD, No B. 168: cervical cancer screening and prevention. Obstet Gynecol. 2016;128:e111–30.
Davies KR, Cantor SB, Cox DD, Follen M. An alternative approach for estimating the accuracy of colposcopy in detecting cervical precancer. PLoS ONE. 2015;10:1–14.
Fokom-Domgue J, Combescure C, Fokom-Defo V, et al. Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies. Br Med J. 2015;351: h3084.
Karimi-Zarchi M, Peighmbari F, Karimi N, et al. A comparison of 3 ways of conventional pap smear, liquid-based cytology and colposcopy vs cervical biopsy for early diagnosis of premalignant lesions or cervical cancer in women with abnormal conventional Pap test. Int J Biomed Sci. 2013;9:205–10.
Lam CT, Krieger MS, Gallagher JE, et al. Design of a novel low cost point of care tampon (POCkeT) colposcope for use in resource limited settings. PLoS ONE. 2015;10:1–22.
Lam CT, Mueller J, Asma B, et al. An integrated strategy for improving contrast, durability, and portability of a Pocket Colposcope for cervical cancer screening and diagnosis. PLoS ONE. 2018;13:1–20.
Mueller JL, Lam CT, Dahl D, et al. Portable pocket colposcopy performs comparably to standard-of-care clinical colposcopy using acetic acid and Lugol’s iodine as contrast mediators: an investigational study in Peru. BJOG An Int J Obstet Gynaecol. 2018;125:1321–9.
Nessa A, Wistrand C, Begum SA, et al. Evaluation of stationary colposcope and the Gynocular, by the Swede score systematic colposcopic system in VIA positive women: a crossover randomized trial. Int J Gynecol Cancer. 2014;24:339–45.
Ngonzi J, Bajunirwe F, Wistrand C, et al. Agreement of colposcope and Gynocular in assessment of cervical lesions by Swede score: a randomized, crossover pilot trial. J Low Genit Tract Dis. 2013;17:372–7.
Özgü E, Yıldız Y, Özgü BS, et al. Efficacy of a real time optoelectronic device (TruscreenTM) in detecting cervical intraepithelial pathologies: a prospective observational study. J Turkish Ger Gynecol Assoc. 2015;16:41–4.
Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in carcinoma of the uterus. Am J Obstet Gynecol. 1941;42:193–206.
Parashari A, Singh V, Sehgal A, et al. Low-cost technology for screening uterine cervical cancer. Bull World Health Organ. 2000;78:964–7.
Pimple SA, Amin G, Goswami S, Shastri SS. Evaluation of colposcopy vs cytology as secondary test to triage women found positive on visual inspection test. Indian J Cancer. 2010;47:308–13.
Pourasad-Shahrak S, Salehi-Pourmehr H, Mostafa-Garebaghi P, et al. Comparing the results of Pap smear and direct visual inspection (DVI) with 5% acetic acid in cervical cancer screening. Niger Med J. 2015;56:35–8.
Pruski D, Przybylski M, Kedzia W, et al. Optoelectronic method for detection of cervical intraepithelial neoplasia and cervical cancer. Opto Electron Rev. 2011;19:478–85.
Qiao L, Li B, Long M, et al. Accuracy of visual inspection with acetic acid and with Lugol’s iodine for cervical cancer screening: meta-analysis. J Obstet Gynaecol Res. 2015;41:1313–25.
Sankaranarayanan R, Basu P, Wesley RS, et al. Accuracy of visual screening for cervical neoplasia: results from an IARC multicentre study in India and Africa. Int J Cancer. 2004;110:907–13.
Sankaranarayanan R, Gaffikin L, Jacob M, et al. A critical assessment of screening methods for cervical neoplasia. Int J Gynecol Obstet. 2005;89:S4–12.
Sankaranarayanan R, Esmy PO, Rajkumar R, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 2007;370:398–406.
Sauvaget C, Fayette JM, Muwonge R, et al. Accuracy of visual inspection with acetic acid for cervical cancer screening. Int J Gynecol Obstet. 2011;113:14–24.
Singh V, Parashari A, Gupta S, et al. Performance of a low cost magnifying device, magnivisualizer, versus colposcope for detection of pre-cancer and cancerous lesions of uterine cervix. J Gynecol Oncol. 2014;25:282–6.
Tanaka Y, Ueda Y, Okazawa A, et al. ‘Smartscopy’ as an alternative device for cervical cancer screening: a pilot study. BMJ Innov. 2017;3:123–6.
Thay S, Goldstein A, Goldstein LS, et al. Prospective cohort study examining cervical cancer screening methods in HIV-positive and HIV-negative Cambodian Women: a comparison of human papilloma virus testing, visualization with acetic acid and digital colposcopy. BMJ Open. 2019;9:1–6.
WHO. Human papillomavirus and cervical cancer. 2019 https://www.who.int/en/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Palo, I., Sahoo, S. & Sravani, T. Cervical Health for a Lifetime: Smartscope a New Armamentarium. Indian J Gynecol Oncolog 22, 57 (2024). https://doi.org/10.1007/s40944-024-00826-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s40944-024-00826-9